These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8876870)

  • 1. Quinolones and tuberculosis.
    Peloquin CA
    Ann Pharmacother; 1996 Sep; 30(9):1034-5. PubMed ID: 8876870
    [No Abstract]   [Full Text] [Related]  

  • 2. New tuberculosis drug development. How can we do better?
    O'Brien RJ; Vernon AA
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1705-7. PubMed ID: 9620895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinolones for the treatment and prophylaxis of tuberculosis.
    Kaplan JA; Krieff DM
    Ann Pharmacother; 1996 Sep; 30(9):1020-2. PubMed ID: 8876865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
    Mishin VIu; Vasil'eva IA; Martynova LP
    Probl Tuberk; 1999; (6):20-2. PubMed ID: 10715950
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of mycobacterial infection--a UK survey.
    Lovering AM; White LO; Acaye C; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1995 Oct; 36(4):745-7. PubMed ID: 8591956
    [No Abstract]   [Full Text] [Related]  

  • 7. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of liposome preparation to treat mycobacterial infections.
    Bermudez LE
    Immunobiology; 1994 Oct; 191(4-5):578-83. PubMed ID: 7713573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of tuberculosis--role of sparfloxacin?
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1999 Jul; 47(7):750. PubMed ID: 10778613
    [No Abstract]   [Full Text] [Related]  

  • 11. Saving quinolones for tuberculosis.
    Bedi RS
    J Assoc Physicians India; 2003 Sep; 51():933-4. PubMed ID: 14710994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
    Mar'iandyshev AO; Klinberg NM; Shonbina AI; Moroz MI
    Probl Tuberk; 1997; (4):19-21. PubMed ID: 9333808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An update on the antibiotic therapy of tuberculosis].
    Rossi G
    Recenti Prog Med; 1999 May; 90(5):241-3. PubMed ID: 10380549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistant tuberculosis.
    Singh M; Jayanthi S; Kumar L
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of defervescence in response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis and advanced human immunodeficiency virus infection.
    Hsieh SM; Sheng WH; Chen MY; Hung CC; Chang SC
    J Formos Med Assoc; 1999 Aug; 98(8):550-5. PubMed ID: 10502908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin for drug-resistant Mycobacterium tuberculosis.
    Peloquin CA; Berning SE; Huitt GA; Iseman MD
    Ann Pharmacother; 1998 Feb; 32(2):268-9. PubMed ID: 9496417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.